Back

Interrogating mechanisms of fluoropyrimidine cardiotoxicity: a prospective stress CMR study

20 June 2026 (10:45 - 11:45)
Organised by: Logo
Congress Presentation Part of: Clinical science in cardio-oncology Research and New Technology Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Aderonke Abiodun

Barts Health Trust, London (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail
Streamlining event ascertainment in cancer randomised controlled trials: accuracy of the SCORE-CVD-MI algorithm using health system data in a large prostate cancer trial
Doctor R. Gonzalez-Manzanares (Cordoba, ES)
Abstract Slides
Presentation thumbnail
Personalised and unified longitudinal surveillance in cardio-oncology (PULSO): design of a digitally enabled multidisciplinary observational study.
Mrs C. Contreras (Madrid, ES)
Abstract Slides
Presentation thumbnail
Deep-learning analysis of 12-lead ECGs detects drug-induced hERG inhibition and improves risk stratification beyond QTc
Doctor M. Liang (US)
Abstract Slides
Presentation thumbnail
Cardiovascular disease in breast cancer patients receiving chemotherapy: epidemiology and risk factors
Doctor V. Dvorovy (Bratislava, SK)
Abstract Slides
Presentation thumbnail
The relationship between cardiovascular disease and survival in patients having cardiac avoidance radiotherapy for lung cancer
Doctor C. Morgan (Manchester, GB)
Abstract Slides

Access the full session

Session thumbnail
Clinical science in cardio-oncology

The Event

Event poster

ESC Cardio-Oncology 2026

20 June 2026 10:45 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources